Pactel

Pactel Bio is a preclinical-stage biotechnology company specializing in the development of engineered extracellular vesicles (EVs) for targeted drug delivery. The company's platform focuses on overcoming the limitations of current delivery vehicles, such as lipid nanoparticles, by utilizing the natural biocompatibility and tissue-homing capabilities of exosomes. Pactel Bio aims to deliver diverse therapeutic payloads, including RNA and proteins, to previously hard-to-reach tissues like the central nervous system. Their approach has applications across a broad range of therapeutic areas, including rare genetic diseases and oncology. By engineering the surface and internal cargo of EVs, the company seeks to create highly specific and potent therapeutic candidates.